Paraneoplastic pemphigus is an autoimmune disease characterized by the formation of blisters that affect the mucous membranes and / or skin.  It falls under the “rare diseases” category and can affect both males and females. According to Ophanet, paraneoplastic pemphigus affects 1 in 2,000 people. It is a rare form of pemphigus usually associated with lymph proliferative disorders such as Castleman disease, chronic lymphocytic leukemia, and non-Hodgkin’s lymphoma. Paraneoplastic pemphigus is a highly serious and rare form of pemphigus, especially due to the underlying malignancy in affected individuals. Its symptoms include respiratory, skin, oral, and other lesions. To diagnose paraneoplastic pemphigus, a blood test is generally carried out to check for the presence of IgG antibodies. After this, signs such as concurrent internal tumor, polymorphic mucocutaneous eruption, and serum antibodies with a specific immunoprecipitation pattern which indicate paraneoplastic pemphigus are checked for. There is no specific treatment for the pemphigus other than supportive measures such as attending to secondary infections and pain management. However, immunomodulators and immunosuppressive agents may be employed.

Factors such as the growing global prevalence of cancer, increasing consumption of tobacco, rising awareness, and unhealthy lifestyles drive the global paraneoplastic pemphigus (PNP) disease market. The rising health care expenditures, favorable insurance coverage, and increasing number of research & development activities are a few more propellants of the global paraneoplastic pemphigus (PNP) disease market. On the other hand, lack of awareness and stringent regulations may hinder the market.

The paraneoplastic pemphigus (PNP) disease market has been segmented by product type into the following categories: immunosuppresants and immunomodulators. The former include prednisolone, azathiprion, cyclosporin, and cyclophosphamide. The latter include gammagard, gamimune, and sandoglobulin.  In terms of distribution channel, the paraneoplastic pemphigus (PNP) disease market is divided into the following sections: hospital pharmacies, retail pharmacies, and online pharmacies.

Geographically, the paraneoplastic pemphigus (PNP) disease market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically, North America dominated the market due to the increasing geriatric population, technological advancements, and strong research & development activities in the region.  Adults between the ages of 45 and 70 years constitute the common demographic affected by the paraneoplastic pemphigus disease; however, the disorder may affect children as well. Europe is the second leading market for the paraneoplastic pemphigus (PNP) disease, propelled by the increasing geriatric population and growing use of tobacco in the region. In 2015, the geriatric population in Europe stood at 129.6 million which is likely to reach 169.1 million and 196.8 million in 2030 and 2050 respectively. The market in Asia Pacific is projected to witness a higher growth rate owing to the rapid surge in population, increasing health care expenditure, favorable health care insurance coverage, and the developing economy of the region. According to Pfizer Inc., 3.6 million males and 4.0 million females in Asia are cancer patients. China alone has 1.6 million male and 1.5 million female cancer survivors. Emerging regions such as Latin America and Middle East & Africa are predicted to create major opportunities for the global paraneoplastic pemphigus (PNP) disease market on account of the growing investment of major market players and increasing private health care insurance coverage here.

Key players operating in this market include F. Hoffmann-La Roche Ltd, Sanofi S.A., Pfizer Inc., Teligent Inc, GlaxoSmithKline LLC, Teva Pharmaceutical Industries, and Novartis International AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Paraneoplastic Pemphigus Disease Market

Pre Book